MVCAX
Price
$35.39
Change
+$0.19 (+0.54%)
Updated
Aug 21 closing price
Net Assets
17.56B
VASVX
Price
$31.67
Change
+$0.28 (+0.89%)
Updated
Aug 21 closing price
Net Assets
6.98B
Interact to see
Advertisement

MVCAX vs VASVX

MVCAX vs VASVX Comparison Chart in %
View a ticker or compare two or three
VS
MVCAX vs. VASVX commentary
Aug 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVCAX is a Hold and VASVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.6B vs. VASVX (6.98B). VASVX pays higher dividends than MVCAX: VASVX (1.69) vs MVCAX (1.09). MVCAX was incepted earlier than VASVX: MVCAX (25 years) vs VASVX (31 years). MVCAX (0.98) is less costly to investors than VASVX (0.34). VASVX is a more actively managed with annual turnover of: 28.00 vs. MVCAX (24.00). MVCAX has a lower initial minimum investment than VASVX: MVCAX (1000) vs VASVX (3000). MVCAX annual gain was more profitable for investors over the last year : 12.11 vs. VASVX (8.85). MVCAX return over 5 years is better than : 20.09 vs. VASVX (2.00).
MVCAXVASVXMVCAX / VASVX
Total Expense Ratio0.970.34285%
Annual Report Gross Expense Ratio0.980.34288%
Fund Existence25 years31 years-
Gain YTD17.06018.36393%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets17.6B6.98B252%
Annual Yield % from dividends1.091.6965%
Returns for 1 year12.118.85137%
Returns for 3 years28.4813.21216%
Returns for 5 years20.092.001,005%
Returns for 10 years85.8613.84620%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGCIX10.49N/A
N/A
Russell Inv Global Infrastructure C
MOGLX11.87-0.06
-0.50%
Gabelli Media Mogul
WLCVX25.73-0.16
-0.62%
Wilshire Large Company Value Instl
GLCUX36.43-0.26
-0.71%
Goldman Sachs Large Cap Gr Insghts R6
JFNNX92.33-1.78
-1.89%
Janus Henderson Global Life Sciences N